OXIS International Executives Interviewed on StockGoodies.com Radio

BEVERLY HILLS, Calif., Oct. 12 /PRNewswire/ -- OXIS International, Inc., (OTC Bulletin Board: OXIS; Paris: OXI) today announced that Anthony Cataldo, Chief Executive Officer, and Bernie Landes, President, will be the featured guest interviewees on StockGoodies.com Radio, one of the fastest growing investor and stock trading communities on the Internet.  

The interview will be held on Tuesday, October 12, 2010, at 8:00 p.m. Eastern time, and can be heard at http://www.blogtalkradio.com/stockgoodies.  An archived version can be found on the homepage of www.StockGoodies.com

During the interview, Mr. Cataldo and Mr. Landes are expected to discuss the wide range of benefits provided by OXIS' versatile antioxidant L-Ergothioneine (ERGO), the upcoming launch of two ERGO-based supplements, and the marketing strategy for introducing additional ERGO-based nutraceuticals and cosmeceuticals.

About StockGoodies

StockGoodies, ranked 3rd highest stock related website on Tim Sykes' investimonials.com, is a highly respected, leading publisher of news, perspective, and stock market education on all forms of trading, covering: pennies, micro-cap, small, mid and large cap equities, foreign exchange and options. StockGoodies mission is to educate & empower self-directed investors, with the vision of building a powerhouse of talented traders, helping each other, narrowing the gap between individual and institutional traders.

About OXIS International, Inc.

OXIS International, Inc. develops technologies and products to research, diagnose, treat and prevent diseases of oxidative stress/inflammation associated with damage from free radical and reactive oxygen species (ROS). The company holds the rights to several therapeutic classes of compounds in the area of oxidative stress, and has focused commercialization programs that include SOD (superoxide dismutase), MPO (myeloperoxidase), GPx (glutathione peroxidase), as well as a highly potent antioxidant, Ergothioneine, that may be sold over-the-counter (OTC) as a dietary supplement. Ergothioneine can also be sold to the cosmetics markets as well as the functional food and beverage markets.

SOURCE OXIS International, Inc.